… COPD patients admitted to hospital for STEMI. Eight hundred and twenty (40%) COPD patients
were on ICS/LABD treatment (of … treatment before STEMI was an independent predictor of …

… ‐line treatment for managing stable COPD in high‐risk people of … bronchodilators, key
medications for symptomatic COPD … Every study included participants with both per cent predicted (…

… treatment with inhaled long-acting bronchodilators (LABA or LAMA) or inhaled corticosteroids
(ICS) which is labeled “treatment … as “on treatment”. Classification according to these three …

… classes of long-acting bronchodilators in COPD, we found that initiation of treatment with …
with tiotropium compared with patients who initiated their treatment with a LABA inhaler, …

… to long-acting bronchodilator therapy is poor. Approximately two thirds of patients fail to continue
treatment after … factors predicting 12-month NP to therapy (treatment gap >90 days) on a …

… to short-acting bronchodilator is not predictive of an … were asked not to use their short- and
long-acting bronchodilators … in our COPD patients still on long-acting bronchodilators. Other …

… been shown to be better predictor of mortality than FEV 1 alone in patients with COPD [19]. …
favorable response to inhaled corticosteroid (ICS)/long-acting β 2 -adrenergic agonist (LABA) …

… COPD, the most appropriate biomarkers and clinical characteristics that reliably predict
treatment … The majority of patients with COPD on long-acting bronchodilator monotherapy remain …

… Although a previous study invented a model to predict EQ5D utility using SGRQ … prediction.
Interestingly, we found that the CAT was the strongest predictor of HRQoL in COPD patients. …

… concomitant long-acting bronchodilation in pure COPD (1). … treatment to date has been
shown to reduce decline in COPD, … with the patient, weighing the burden, predicted effects, and …